From the aISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; bUniversitat Pompeu Fabra, Barcelona, Spain; cCIBER Epidemiología y Salud Pública, Madrid, Spain; dDepartment of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; eNuvia Limited, Didcot, United Kingdom; fCommissariat à l'Energie Atomique, Fontenay-aux-Roses, France; gAtomic Weapons Establishment, Aldermaston, United Kingdom; hPublic Health England, Didcot & Moor Row, United Kingdom; iInstitut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; JInstitut de Veille Sanitaire, Saint Maurice, France; kOccupational Cancer Research Centre, Toronto, ON, Canada; lStudiecentrum voor Kernenergie • Centre d'Étude de l'énergie Nucléaire, Mol, Belgium; mUK Atomic Energy Authority, Culham, United Kingdom; nAutorité de Sûreté Nucléaire, Paris, France; and oInternational Agency for Research on Cancer, Lyon, France.
Epidemiology. 2017 Sep;28(5):675-684. doi: 10.1097/EDE.0000000000000684.
Carcinogenic risks of internal exposures to alpha-emitters (except radon) are poorly understood. Since exposure to alpha particles-particularly through inhalation-occurs in a range of settings, understanding consequent risks is a public health priority. We aimed to quantify dose-response relationships between lung dose from alpha-emitters and lung cancer in nuclear workers.
We conducted a case-control study, nested within Belgian, French, and UK cohorts of uranium and plutonium workers. Cases were workers who died from lung cancer; one to three controls were matched to each. Lung doses from alpha-emitters were assessed using bioassay data. We estimated excess odds ratio (OR) of lung cancer per gray (Gy) of lung dose.
The study comprised 553 cases and 1,333 controls. Median positive total alpha lung dose was 2.42 mGy (mean: 8.13 mGy; maximum: 316 mGy); for plutonium the median was 1.27 mGy and for uranium 2.17 mGy. Excess OR/Gy (90% confidence interval)-adjusted for external radiation, socioeconomic status, and smoking-was 11 (2.6, 24) for total alpha dose, 50 (17, 106) for plutonium, and 5.3 (-1.9, 18) for uranium.
We found strong evidence for associations between low doses from alpha-emitters and lung cancer risk. The excess OR/Gy was greater for plutonium than uranium, though confidence intervals overlap. Risk estimates were similar to those estimated previously in plutonium workers, and in uranium miners exposed to radon and its progeny. Expressed as risk/equivalent dose in sieverts (Sv), our estimates are somewhat larger than but consistent with those for atomic bomb survivors.See video abstract at, http://links.lww.com/EDE/B232.
内照射 α 放射物(氡除外)致癌风险尚未被充分认识。由于 α 粒子的内照射(尤其是吸入)发生于一系列环境中,因此了解其相关风险是公共卫生的当务之急。我们旨在定量研究 α 放射物所致肺剂量与核工业工人肺癌之间的剂量-反应关系。
我们进行了一项病例对照研究,该研究嵌套于比利时、法国和英国铀和钚作业工人队列中。病例为死于肺癌的工人,每位病例匹配 1 至 3 位对照。采用生物检测数据评估 α 放射物所致肺剂量。我们估计每戈瑞(Gy)肺剂量下肺癌的超额比值比(OR)。
该研究纳入了 553 例病例和 1333 例对照。阳性总α肺剂量的中位数为 2.42 毫戈瑞(均值:8.13 毫戈瑞;最大值:316 毫戈瑞);钚的中位数为 1.27 毫戈瑞,铀的中位数为 2.17 毫戈瑞。经外部辐射、社会经济地位和吸烟因素校正后,总 α 剂量的超额 OR/Gy(90%置信区间)为 11(2.6,24),钚为 50(17,106),铀为 5.3(-1.9,18)。
我们发现低剂量 α 放射物与肺癌风险之间存在很强的关联证据。与铀相比,钚的超额 OR/Gy 更高,尽管置信区间有重叠。风险估计与先前在钚作业工人和暴露于氡及其子体的铀矿工人中的估计相似。以等效剂量(Sv)表示的风险估计值略高于但与原子弹幸存者的结果一致。